Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis

医学 内科学 荟萃分析 置信区间 加药 科克伦图书馆 相对风险 治疗药物监测 联合疗法 外科 药代动力学
作者
Wen‐Liang Dong,Xiaowen Hu,Caiying Wu,Gengchen Wang,Yi Fang,Luwen Shi,Xiaoyan Nie
出处
期刊:Seminars in Arthritis and Rheumatism [Elsevier BV]
卷期号:63: 152302-152302 被引量:4
标识
DOI:10.1016/j.semarthrit.2023.152302
摘要

The benefits of TDM-guided TNFi therapy in patients with rheumatic disease was still controversial. This systematic review and meta-analysis was conducted to explore if the TDM-guided TNFi therapy is superior to empirical-guided therapy. We systematically searched PubMed, Web of Science, Cochrane Library, and EMBASE databases for articles published between database inception and October 05, 2023. Studies reporting endpoints in TDM-guided TNFi therapy and empirical therapy were included. Results would be presented in risk ratio (RR) and mean difference, with 95 % confidence interval (CI) reported. This study is registered with PROSPERO (CRD42022353956). A total of 14 studies (eight RCTs and six cohort studies) involving 2427 patients were included in this meta-analysis. In the scenario of response prediction, compared with empirical-guided therapy, TDM-guided TNFi therapy had association with higher treat-to-target rates (RR 1.30, 95 % CI 1.02-1.65, P=0.03, I2=79 %), more specifically, higher low disease activity rates (RR 2.11, 95 % CI 1.22-3.66, P=0.007, I2=61 %), but no difference in clinical remission rates (RR 0.98,95 % CI 0.87-1.11, P=0.75, I2=0 %). In the scenario of dose reduction prediction, lower relapse rates (RR 0.73, 95 % CI 0.65-0.82, P <0.00001, I2=0 %) were observed compared with empirical-guided dose reduction strategy, but no difference (RR 1.24, 95 % CI 0.85-1.80, P=0.27, I2=57 %) between TDM-guided dose reduction and standard-dosing therapy. No significant difference was observed in change of disease activity score, mean disease activity score, radiographic progression, and safety. And TDM-guided therapy was associated with reduced cost per patient per year calculated as the total accumulated sum of therapy cost. TDM-guided TNFi therapy was associated with increased rates of low disease activity and decreased risks of relapse, and may save cost compared with empirical-guided therapy in patients with rheumatic disease. But this does not mean that the use of TDM-guided TNFi therapy can be advocated, because there is no difference in clinical remission rates and many other outcomes. More researches, especially randomized clinical trials are needed to verify this conclusion in the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
李风完成签到,获得积分10
1秒前
1秒前
何文微发布了新的文献求助10
1秒前
1秒前
1秒前
初景发布了新的文献求助10
2秒前
3秒前
花墨完成签到,获得积分10
3秒前
zyy发布了新的文献求助10
3秒前
3秒前
共享精神的应助被大气的山彤采纳,获得10
4秒前
4秒前
LiSiyi完成签到 ,获得积分10
5秒前
ian发布了新的文献求助10
5秒前
5秒前
充电宝的应助被dde采纳,获得10
6秒前
6秒前
youth的应助被dde采纳,获得10
6秒前
6秒前
烟花的应助被dde采纳,获得10
6秒前
坚强孤容发布了新的文献求助10
6秒前
6秒前
万能图书馆的应助被dde采纳,获得10
6秒前
科研通AI6.3的应助被dde采纳,获得10
6秒前
wangyue1230发布了新的文献求助10
6秒前
科研通AI65的应助被dde采纳,获得10
7秒前
Akim的应助被dde采纳,获得10
7秒前
科研通AI6.3的应助被dde采纳,获得10
7秒前
7秒前
syvshc的应助被dde采纳,获得10
7秒前
背后的小白菜完成签到,获得积分10
7秒前
123完成签到,获得积分20
7秒前
科研通AI6.3的应助被dde采纳,获得10
7秒前
yy发布了新的文献求助10
8秒前
nnam发布了新的文献求助10
8秒前
易博完成签到,获得积分10
8秒前
李健的小迷弟的应助被joan采纳,获得10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187328
求助须知:如何正确求助?哪些是违规求助? 9575427
关于积分的说明 21841244
捐赠科研通 7784994
什么是DOI,文献DOI怎么找? 3434935
关于科研通互助平台的介绍 2559375
邀请新用户注册赠送积分活动 2481820